Side effects of anabolic androgenic steroids abuse

被引:69
作者
Bonetti, A. [1 ]
Tirelli, F. [1 ]
Catapano, A. [2 ]
Dazzi, D. [3 ]
Cas, A. Dei [3 ]
Solito, F. [1 ]
Ceda, G. [3 ]
Reverberi, C. [4 ]
Monica, C. [5 ]
Pipitone, S. [5 ]
Elia, G. [6 ]
Spattini, M. [1 ]
Magnati, G. [3 ]
机构
[1] Univ Parma, Dept Clin Sci, Curriculum Sports Sci & Phys Exercise, I-43100 Parma, Italy
[2] Univ Milan, Dept Phamacol Sci, Milan, Italy
[3] Univ Parma, Dept Internl Med & Biomed Sci, I-43100 Parma, Italy
[4] Univ Parma, Dept Heart & Cardiac Surg, Azienda Osped, I-43100 Parma, Italy
[5] Univ Parma, Cent Lab, Azienda Osped, I-43100 Parma, Italy
[6] Univ Parma, Infect Dis Sect, Azienda Osped, I-43100 Parma, Italy
关键词
anabolic androgenic steroids; bodybuilders; side effects; doping;
D O I
10.1055/s-2007-965808
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Long-term side effects of high doses of anabolic androgenic steroids self-administration were evaluated in this study. Twenty male bodybuilders, voluntarily starting steroid self-administration, were followed every 6 months over 2 years. Physical examination, haematological, metabolic and endocrine variables, semen analysis, hepatic and prostate ultrasound and echocardiographic evaluations were performed. LH values (baseline 3.43 +/- 1.75) were suppressed at 18 (1.98 +/- 1.99) (p = 0.026) and 24 (2.43 +/- 2.17) (p = 0.026), and FSH (3.95 +/- 2.01) at 6 (3.01 +/- 2.16) (p = 0.031), 12 (2.45 +/- 2.54) (p = 0.029), 18 (2.02 +/- 2.29) (p = 0.032) and 24 (3.42 +/- 2.64) (p = 0.032) months and SHBG (34.11 +/- 10.88) Values significantly lowered at 12 (24.81 +/- 12.49) (p < 0.05), IS (21.28 +/- 11.15) (p < 0.01), 24 months (25.42 +/- 11.16) (p < 0.01). A significant decrease in spermatozoa count (p < 0.01), and fertility index (p = 0.01) occurred. HDL-cholesterol (baseline 56.94 +/- 13.54) was reduced at 18 (41.86 +/- 14.17) (p < 0.01) and 24 (43.82 +/- 18.67) (p < 0.05) months and Apo A-1 at 12 (p < 0.001), 18 (p = 0.05) and 24 (p = 0.05) months. The most important long-term adverse effects were lower fertility and the impairment of lipid profile associated with an increased cardiovascular risk.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 52 条
[1]   ANDROGENIC-ANABOLIC STEROID EFFECTS ON SERUM THYROID, PITUITARY AND STEROID-HORMONES IN ATHLETES [J].
ALEN, M ;
RAHKILA, P ;
REINILA, M ;
VIHKO, R .
AMERICAN JOURNAL OF SPORTS MEDICINE, 1987, 15 (04) :357-361
[2]   MYOCARDIAL-INFARCTION, HYPERKALEMIA AND VENTRICULAR-TACHYCARDIA IN A YOUNG MALE BODY-BUILDER [J].
APPLEBY, M ;
FISHER, M ;
MARTIN, M .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1994, 44 (02) :171-174
[3]   Drug therapy - Androgens in men - Uses and abuses [J].
Bagatell, CJ ;
Bremner, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :707-714
[4]  
Baldi JC, 2003, INT J SPORTS MED, V24, P419, DOI 10.1055/s-2003-41173
[5]   Proof of the effect of testosterone on skeletal muscle [J].
Bhasin, S ;
Woodhouse, L ;
Storer, TW .
JOURNAL OF ENDOCRINOLOGY, 2001, 170 (01) :27-38
[6]   The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men [J].
Bhasin, S ;
Storer, TW ;
Berman, N ;
Callegari, C ;
Clevenger, B ;
Phillips, J ;
Bunnell, TJ ;
Tricker, R ;
Shirazi, A ;
Casaburi, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (01) :1-7
[7]   Steroids and steroid-like compounds [J].
Blue, JG ;
Lombardo, JA .
CLINICS IN SPORTS MEDICINE, 1999, 18 (03) :667-+
[8]   Exercise and insulin sensitivity: A review [J].
Borghouts, LB ;
Keizer, HA .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2000, 21 (01) :1-12
[9]  
BOYARDJIEV NP, 2001, J SPORTS MED PHYS FI, V40, P271
[10]  
Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102